Skip to main content Accessibility help
×
Home
Hostname: page-component-568f69f84b-ftpnm Total loading time: 0.32 Render date: 2021-09-16T22:15:34.852Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Hepatitis A antibody prevalence among young adults in Israel – the decline continues

Published online by Cambridge University Press:  01 October 1998

M. GDALEVICH
Affiliation:
Medical Corps, Israel Defense Force
I. GROTTO
Affiliation:
Medical Corps, Israel Defense Force
Y. MANDEL
Affiliation:
Medical Corps, Israel Defense Force
D. MIMOUNI
Affiliation:
Medical Corps, Israel Defense Force
J. SHEMER
Affiliation:
Medical Corps, Israel Defense Force Sackler Medical School, Tel Aviv University, Israel
I. ASHKENAZI
Affiliation:
Medical Corps, Israel Defense Force Sackler Medical School, Tel Aviv University, Israel
Rights & Permissions[Opens in a new window]

Abstract

HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This study sought to determine whether the decline in prevalence of hepatitis A virus (HAV) antibodies detected in Israel in 1977, 1984, and 1987 has continued. The anti-HAV antibody prevalence of a systematic sample of 578 male and female recruits inducted into the Israel Defence Force in 1996 was 38·4%. The reduction in antibody prevalence from 1977 (64%) was highly significant (P<0·001). There was a smaller decrease rate in recruits of European, North American, Australian and South African origin than from elsewhere. A ‘strategy’ that uses active immunization against hepatitis A (inactivated vaccine, instead of gamma globulin) should be considered, particularly in high risk groups such as field units during military service.

Type
SHORT PAPER
Copyright
© 1998 Cambridge University Press
You have Access
24
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Hepatitis A antibody prevalence among young adults in Israel – the decline continues
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Hepatitis A antibody prevalence among young adults in Israel – the decline continues
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Hepatitis A antibody prevalence among young adults in Israel – the decline continues
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *